Assignee profile:

ONCOLYTICS BIOTECH INC.

City:

Calgary

Country:

Canada

Published Applications:

55

Last publication date:

2020-07-30

Patent Grants:

42

Last grant date:

2022-02-15

Top Inventors for applications by ONCOLYTICS BIOTECH INC.

These are the the leading inventors for applications assigned to ONCOLYTICS BIOTECH INC.:

Recent patent applications by ONCOLYTICS BIOTECH INC.

ONCOLYTICS BIOTECH INC. based in Calgary, CA has been assigned the rights to these inventions. The list includes both Pending Applications and Patent Grants:

#1 | 2020-07-30 ✅ Patent 11,246,930 granted on 2022-02-15
US20200237917A1
Human necessities

Reoviruses having modified sequences

#2 | 2015-08-13 ✅ Patent 9,610,352 granted on 2017-04-04
US20150224198A1
Human necessities

Lyophilized viral formulations

#3 | 2015-08-13 ✅ Patent 9,610,309 granted on 2017-04-04
US20150224155A1
Human necessities

Liquid viral formulations

#4 | 2014-07-03 ✅ Patent 10,039,827 granted on 2018-08-07
US20140186301A1
Chemistry; metallurgy

Reoviruses having modified sequences

#5 | 2014-06-26 ✅ Patent 10,167,452 granted on 2019-01-01
US20140178969A1
Chemistry; metallurgy

Viral purification methods

#6 | 2013-10-17 ✅ Patent 9,365,823 granted on 2016-06-14
US20130273012A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#7 | 2013-09-19
US20130243732A1
Human necessities

ABROGATING PROINFLAMMATORY CYTOKINE PRODUCTION DURING ONCOLYTIC REOVIRUS THERAPY

#8 | 2013-01-24 ✅ Patent 8,609,331 granted on 2013-12-17
US20130022964A1
Chemistry; metallurgy

Use of ribozymes in the detection of adventitious agents

#9 | 2013-01-17 ✅ Patent 8,658,158 granted on 2014-02-25
US20130017172A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#10 | 2012-11-01
US20120273424A1
Performing operations; transporting

METHODS OF PURIFYING VIRUSES USING GEL PERMEATION CHROMATOGRAPHY

#11 | 2012-09-06 ✅ Patent 8,512,712 granted on 2013-08-20
US20120225045A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#12 | 2012-06-21 ✅ Patent 8,491,886 granted on 2013-07-23
US20120156168A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#13 | 2012-06-07 ✅ Patent 9,044,498 granted on 2015-06-02
US20120141528A1
Human necessities

Lyophilized viral formulations

#14 | 2012-06-07 ✅ Patent 8,709,443 granted on 2014-04-29
US20120141426A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#15 | 2012-06-07 ✅ Patent 9,045,728 granted on 2015-06-02
US20120141421A1
Human necessities

Liquid viral formulations

#16 | 2011-10-06
US20110243890A1
Human necessities

Sensitization of Chemotherapeutic Agent Resistant Neoplastic Cells With a Virus

#17 | 2011-08-18 ✅ Patent 8,491,884 granted on 2013-07-23
US20110200565A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#18 | 2011-01-27 ✅ Patent 8,691,241 granted on 2014-04-08
US20110020288A1
Human necessities

Reoviruses having modified sequences

#19 | 2011-01-20 ✅ Patent 8,071,087 granted on 2011-12-06
US20110014155A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#20 | 2010-09-30 ✅ Patent 8,147,845 granted on 2012-04-03
US20100248205A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#21 | 2010-08-12 ✅ Patent 8,080,241 granted on 2011-12-20
US20100203147A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#22 | 2010-06-10 ✅ Patent 8,298,785 granted on 2012-10-30
US20100143892A1
Chemistry; metallurgy

Use of ribozymes in the detection of adventitious agents

#23 | 2010-04-29 ✅ Patent 8,222,036 granted on 2012-07-17
US20100105122A1
Physics

Oncolytic viruses as phenotyping agents for neoplasms

#24 | 2010-01-28 ✅ Patent 7,964,187 granted on 2011-06-21
US20100021432A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#25 | 2009-05-07 ✅ Patent 8,066,985 granted on 2011-11-29
US20090117082A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#26 | 2009-04-30
US20090110665A1
Chemistry; metallurgy

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#27 | 2009-04-16
US20090098089A1
Chemistry; metallurgy

REOVIRUS FOR THE TREATMENT OF NEOPLASIA

#28 | 2008-11-27
US20080292594A1
Chemistry; metallurgy

MUTANT REOVIRUSES AND METHODS OF MAKING AND USING

#29 | 2008-09-18 ✅ Patent 7,803,385 granted on 2010-09-28
US20080226602A1
Human necessities

Reoviruses having modified sequences

#30 | 2008-04-03
US20080081032A1
Human necessities

Method for reducing pain using oncolytic viruses

#31 | 2008-03-27 ✅ Patent 7,708,987 granted on 2010-05-04
US20080075729A1
Human necessities

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#32 | 2008-02-14
US20080038822A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#33 | 2008-02-07 ✅ Patent 7,727,534 granted on 2010-06-01
US20080032279A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#34 | 2008-02-07 ✅ Patent 7,964,186 granted on 2011-06-21
US20080031886A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#35 | 2008-02-07 ✅ Patent 7,608,257 granted on 2009-10-27
US20080031851A1
Human necessities

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#36 | 2008-01-31
US20080026048A1
Human necessities

Reovirus for the treatment of cellular proliferative disorders

#37 | 2008-01-24 ✅ Patent 7,582,289 granted on 2009-09-01
US20080019981A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#38 | 2008-01-24 ✅ Patent 7,799,329 granted on 2010-09-21
US20080019980A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#39 | 2008-01-17
US20080014577A1
Physics

Oncolytic viruses as phenotyping agents for neoplasms

#40 | 2007-11-22 ✅ Patent 8,685,734 granted on 2014-04-01
US20070269856A1
Chemistry; metallurgy

Viral purification methods

#41 | 2007-09-04 ✅ Patent 7,264,798 granted on 2007-09-04
US10076074
-

Sensitization of chemotherapeutic agent resistant neoplastic cells with a virus

#42 | 2007-08-16
US20070190032A1
Human necessities

Use of Local Immune Suppression to Enhance Oncolytic Viral Therapy

#43 | 2007-05-29 ✅ Patent 7,223,585 granted on 2007-05-29
US10424985
-

Viral purification methods

#44 | 2007-04-19 ✅ Patent 7,731,951 granted on 2010-06-08
US20070086984A1
Human necessities

Viruses for the treatment of cellular proliferative disorders

#45 | 2007-01-16 ✅ Patent 7,163,678 granted on 2007-01-16
US10704531
-

Reovirus for the treatment of ral-mediated cellular proliferative disorders

#46 | 2006-08-03 ✅ Patent 7,815,914 granted on 2010-10-19
US20060172288A1
Physics

Methods for the treatment of cellular proliferative disorders

#47 | 2006-07-27 ✅ Patent 7,429,485 granted on 2008-09-30
US20060165724A1
Human necessities

Method of producing infectious reovirus

#48 | 2006-05-30 ✅ Patent 7,052,832 granted on 2006-05-30
US9985756
-

Methods for the treatment of cellular proliferative disorders

#49 | 2006-04-27 ✅ Patent 7,901,921 granted on 2011-03-08
US20060088869A1
Chemistry; metallurgy

Viral purification methods

#50 | 2006-04-06 ✅ Patent 7,452,723 granted on 2008-11-18
US20060073166A1
Human necessities

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#51 | 2006-03-21 ✅ Patent 7,014,847 granted on 2006-03-21
US10401032
-

Methods for preventing reovirus recognition for the treatment of cellular proliferative disorders

#52 | 2006-02-09 ✅ Patent 7,431,932 granted on 2008-10-07
US20060029598A1
Chemistry; metallurgy

Reovirus clearance of ras-mediated neoplastic cells from mixed cellular compositions

#53 | 2005-05-05 ✅ Patent 7,186,542 granted on 2007-03-06
US20050095692A1
Chemistry; metallurgy

Method of extracting virus from cell culture

#54 | 2005-02-03
US20050026289A1
Chemistry; metallurgy

Virus clearance of neoplastic cells from mixed cellular compositions

#55 | 2005-01-27
US20050019308A1
Human necessities

Oncolytic viruses for the treatment of neoplasms having activated PP2A or Rac

Also check out Oncolytics Biotech Inc.'s (Calgary, Canada) applicant profile with 7 patent applications submitted.

AssigneeID:

4686 ⎘